{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:17:22Z","timestamp":1793654242786,"version":"4.5.1"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mamm Genome"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00335-019-09793-5","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T02:21:54Z","timestamp":1551320514000},"page":"90-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Treating Rett syndrome: from mouse models to human therapies"],"prefix":"10.1007","volume":"30","author":[{"given":"Neeti","family":"Vashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica J.","family":"Justice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"9793_CR1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1012104107","author":"APL Abdala","year":"2010","unstructured":"Abdala APL, Dutschmann M, Bissonnette JM, Paton JFR (2010) Correction of respiratory disorders in a mouse model of Rett syndrome. Proc Natl Acad Sci. \n                    https:\/\/doi.org\/10.1073\/pnas.1012104107","journal-title":"Proc Natl Acad Sci"},{"key":"9793_CR2","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2013-0372OC","author":"AP Abdala","year":"2014","unstructured":"Abdala AP, Lioy DT, Garg SK et al (2014) Effect of sarizotan, a 5-HT1aand D2-like receptor agonist, on respiration in three mouse models of rett syndrome. Am J Respir Cell Mol Biol. \n                    https:\/\/doi.org\/10.1165\/rcmb.2013-0372OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"9793_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1113\/JP270966","volume":"594","author":"AP Abdala","year":"2016","unstructured":"Abdala AP, Toward MA, Dutschmann M et al (2016) Deficiency of GABAergic synaptic inhibition in the K\u00f6lliker-Fuse area underlies respiratory dysrhythmia in a mouse model of Rett syndrome. J Physiol 594:223\u2013237. \n                    https:\/\/doi.org\/10.1113\/JP270966","journal-title":"J Physiol"},{"key":"9793_CR4","first-page":"161","volume":"23","author":"AR Alpoz","year":"1999","unstructured":"Alpoz AR, Ergul N, Oncag O (1999) Bruxism in Rett syndrome: a case report. J Clin Pediatr Dent 23:161\u2013163","journal-title":"J Clin Pediatr Dent"},{"key":"9793_CR5","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1523\/JNEUROSCI.5499-06.2007","volume":"27","author":"MD Amaral","year":"2007","unstructured":"Amaral MD, Pozzo-Miller L (2007) TRPC3 channels are necessary for brain-derived neurotrophic factor to activate a nonselective cationic current and to Induce dendritic spine formation. J Neurosci 27:5179\u20135189. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.5499-06.2007","journal-title":"J Neurosci"},{"key":"9793_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","volume":"23","author":"RE Amir","year":"1999","unstructured":"Amir RE, Van den Veyver IB, Wan M et al (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185\u2013188. \n                    https:\/\/doi.org\/10.1038\/13810","journal-title":"Nat Genet"},{"key":"9793_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1750-1172-9-87","volume":"9","author":"A Anderson","year":"2014","unstructured":"Anderson A, Wong K, Jacoby P et al (2014) Twenty years of surveillance in Rett syndrome: what does this tell us? Orphanet J Rare Dis 9:87. \n                    https:\/\/doi.org\/10.1186\/1750-1172-9-87","journal-title":"Orphanet J Rare Dis"},{"key":"9793_CR8","first-page":"S89","volume":"14","author":"DD Armstrong","year":"1992","unstructured":"Armstrong DD (1992) The neuropathology of the Rett syndrome. Brain Dev 14:S89\u2013S98","journal-title":"Brain Dev"},{"key":"9793_CR9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/jhg.2011.50","volume":"56","author":"R Artuso","year":"2011","unstructured":"Artuso R, Papa FT, Grillo E et al (2011) Investigation of modifier genes within copy number variations in Rett syndrome. J Hum Genet 56:508\u2013515. \n                    https:\/\/doi.org\/10.1038\/jhg.2011.50","journal-title":"J Hum Genet"},{"key":"9793_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.npep.2004.11.001","volume":"39","author":"AM Baker","year":"2005","unstructured":"Baker AM, Batchelor DC, Thomas GB et al (2005) Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat. Neuropeptides 39:81\u201387. \n                    https:\/\/doi.org\/10.1016\/j.npep.2004.11.001","journal-title":"Neuropeptides"},{"key":"9793_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nn.2275","volume":"12","author":"N Ballas","year":"2009","unstructured":"Ballas N, Lioy DT, Grunseich C, Mandel G (2009) Non\u2013cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 12:311\u2013317. \n                    https:\/\/doi.org\/10.1038\/nn.2275","journal-title":"Nat Neurosci"},{"key":"9793_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1172\/JCI7866","volume":"104","author":"ER Barton-Davis","year":"1999","unstructured":"Barton-Davis ER, Cordier L, Shoturma DI et al (1999) Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 104:375\u2013381. \n                    https:\/\/doi.org\/10.1172\/JCI7866","journal-title":"J Clin Invest"},{"key":"9793_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ajmg.a.36850","volume":"167","author":"E Berry-Kravis","year":"2015","unstructured":"Berry-Kravis E, Levin R, Shah H et al (2015) Cholesterol levels in Fragile X syndrome. Am J Med Genet A 167:379\u2013384. \n                    https:\/\/doi.org\/10.1002\/ajmg.a.36850","journal-title":"Am J Med Genet A"},{"key":"9793_CR14","doi-asserted-by":"publisher","first-page":"12591","DOI":"10.1073\/pnas.1413620111","volume":"111","author":"S Bhatnagar","year":"2014","unstructured":"Bhatnagar S, Zhu X, Ou J et al (2014) Genetic and pharmacological reactivation of the mammalian inactive X chromosome. Proc Natl Acad Sci 111:12591\u201312598. \n                    https:\/\/doi.org\/10.1073\/pnas.1413620111","journal-title":"Proc Natl Acad Sci"},{"key":"9793_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/978-90-481-8622-8_11","volume":"51","author":"X Bi","year":"2010","unstructured":"Bi X, Liao G (2010) Cholesterol in niemann\u2013pick type C disease. Subcell Biochem 51:319\u2013335. \n                    https:\/\/doi.org\/10.1007\/978-90-481-8622-8_11","journal-title":"Subcell Biochem"},{"key":"9793_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/jhg.2015.118","volume":"61","author":"L Bianciardi","year":"2016","unstructured":"Bianciardi L, Fichera M, Failla P et al (2016) MECP2 missense mutations outside the canonical MBD and TRD domains in males with intellectual disability. J Hum Genet 61:95\u2013101. \n                    https:\/\/doi.org\/10.1038\/jhg.2015.118","journal-title":"J Hum Genet"},{"key":"9793_CR17","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/hmg\/9.9.1377","volume":"9","author":"T Bienvenu","year":"2000","unstructured":"Bienvenu T, Carri\u00e9 A, de Roux N et al (2000) MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet 9:1377\u20131384","journal-title":"Hum Mol Genet"},{"key":"9793_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep19796","author":"T Bittolo","year":"2016","unstructured":"Bittolo T, Raminelli CA, Deiana C et al (2016) Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice. Sci Rep. \n                    https:\/\/doi.org\/10.1038\/srep19796","journal-title":"Sci Rep"},{"key":"9793_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ajpath.2013.03.019","volume":"183","author":"C Bodda","year":"2013","unstructured":"Bodda C, Tantra M, Mollajew R et al (2013) Mild overexpression of Mecp2 in mice causes a higher susceptibility toward seizures. Am J Pathol 183:195\u2013210. \n                    https:\/\/doi.org\/10.1016\/j.ajpath.2013.03.019","journal-title":"Am J Pathol"},{"key":"9793_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr602","author":"S Braun","year":"2012","unstructured":"Braun S, Kottwitz D, Nuber UA (2012) Pharmacological interference with the glucocorticoid system influences symptoms and lifespan in a mouse model of Rett syndrome. Hum Mol Genet. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddr602","journal-title":"Hum Mol Genet"},{"key":"9793_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00109-010-0704-4","volume":"89","author":"C Brendel","year":"2011","unstructured":"Brendel C, Belakhov V, Werner H et al (2011) Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model. J Mol Med 89:389\u2013398. \n                    https:\/\/doi.org\/10.1007\/s00109-010-0704-4","journal-title":"J Mol Med"},{"key":"9793_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/hmg\/ddv496","volume":"25","author":"K Brown","year":"2016","unstructured":"Brown K, Selfridge J, Lagger S et al (2016) The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome. Hum Mol Genet 25:558\u2013570. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddv496","journal-title":"Hum Mol Genet"},{"key":"9793_CR23","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/ng.2714","volume":"45","author":"CM Buchovecky","year":"2013","unstructured":"Buchovecky CM, Turley SD, Brown HM et al (2013) A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome. Nat Genet 45:1013\u20131020. \n                    https:\/\/doi.org\/10.1038\/ng.2714","journal-title":"Nat Genet"},{"key":"9793_CR24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1715124115","author":"LLG Carrette","year":"2017","unstructured":"Carrette LLG, Wang C-Y, Wei C et al (2017) A mixed modality approach towards Xi reactivation for Rett syndrome and other X-linked disorders. Proc Natl Acad Sci. \n                    https:\/\/doi.org\/10.1073\/pnas.1715124115","journal-title":"Proc Natl Acad Sci"},{"key":"9793_CR25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1800931115","author":"LLG Carrette","year":"2018","unstructured":"Carrette LLG, Blum R, Ma W et al (2018) Tsix\u2013Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function. Proc Natl Acad Sci. \n                    https:\/\/doi.org\/10.1073\/pnas.1800931115","journal-title":"Proc Natl Acad Sci"},{"key":"9793_CR26","doi-asserted-by":"publisher","first-page":"9941","DOI":"10.1073\/pnas.1311685111","volume":"111","author":"J Castro","year":"2014","unstructured":"Castro J, Garcia RI, Kwok S et al (2014) Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett syndrome. Proc Natl Acad Sci 111:9941\u20139946. \n                    https:\/\/doi.org\/10.1073\/pnas.1311685111","journal-title":"Proc Natl Acad Sci"},{"key":"9793_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0092-8674(88)90479-5","volume":"53","author":"H Cedar","year":"1988","unstructured":"Cedar H (1988) DNA methylation and gene activity. Cell 53:3\u20134","journal-title":"Cell"},{"key":"9793_CR28","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","volume":"56","author":"M Chahrour","year":"2007","unstructured":"Chahrour M, Zoghbi HY (2007) The story of Rett syndrome: from clinic to neurobiology. Neuron 56:422\u2013437","journal-title":"Neuron"},{"key":"9793_CR29","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.1153252","volume":"320","author":"M Chahrour","year":"2008","unstructured":"Chahrour M, Jung SYY, Shaw C et al (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320:1224\u20131229. \n                    https:\/\/doi.org\/10.1126\/science.1153252","journal-title":"Science"},{"key":"9793_CR30","doi-asserted-by":"publisher","first-page":"7008","DOI":"10.1021\/bi990224y","volume":"38","author":"SP Chandler","year":"1999","unstructured":"Chandler SP, Guschin D, Landsberger N, Wolffe AP (1999) The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry 38:7008\u20137018. \n                    https:\/\/doi.org\/10.1021\/bi990224y","journal-title":"Biochemistry"},{"key":"9793_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","volume":"49","author":"Q Chang","year":"2006","unstructured":"Chang Q, Khare G, Dani V et al (2006) The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49:341\u2013348. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2005.12.027","journal-title":"Neuron"},{"key":"9793_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nature09582","volume":"468","author":"H-TT Chao","year":"2010","unstructured":"Chao H-TT, Chen H, Samaco RC et al (2010) Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468:263\u2013269. \n                    https:\/\/doi.org\/10.1038\/nature09582","journal-title":"Nature"},{"key":"9793_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/85906","volume":"27","author":"RZ Chen","year":"2001","unstructured":"Chen RZ, Akbarian S, Tudor M, Jaenisch R (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27:327\u2013331. \n                    https:\/\/doi.org\/10.1038\/85906","journal-title":"Nat Genet"},{"key":"9793_CR34","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1126\/science.1086446","volume":"302","author":"WG Chen","year":"2003","unstructured":"Chen WG, Chang Q, Lin Y et al (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302:885\u2013889. \n                    https:\/\/doi.org\/10.1126\/science.1086446","journal-title":"Science"},{"key":"9793_CR35","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.cell.2017.04.035","volume":"169","author":"Y Chen","year":"2017","unstructured":"Chen Y, Yu J, Niu Y et al (2017) Modeling Rett syndrome ising TALEN-Edited MECP2 mutant cynomolgus monkeys. Cell 169:945\u2013955.e10. \n                    https:\/\/doi.org\/10.1016\/j.cell.2017.04.035","journal-title":"Cell"},{"key":"9793_CR36","first-page":"1","volume":"15","author":"EWM Chin","year":"2018","unstructured":"Chin EWM, Lim WM, Ma D et al (2018) Choline rescues behavioural deficits in a mouse model of Rett syndrome by modulating neuronal plasticity. Mol Neurobiol 15:1\u20135","journal-title":"Mol Neurobiol"},{"key":"9793_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuron.2011.08.022","volume":"72","author":"S Cohen","year":"2011","unstructured":"Cohen S, Gabel HW, Hemberg M et al (2011) Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72:72\u201385. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2011.08.022","journal-title":"Neuron"},{"key":"9793_CR38","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","volume":"13","author":"AL Collins","year":"2004","unstructured":"Collins AL, Levenson JM, Vilaythong AP et al (2004) Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 13:2679\u20132689. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddh282","journal-title":"Hum Mol Genet"},{"key":"9793_CR39","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ceb.2005.04.005","volume":"17","author":"E Conti","year":"2005","unstructured":"Conti E, Izaurralde E (2005) Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species. Curr Opin Cell Biol 17:316\u2013325","journal-title":"Curr Opin Cell Biol"},{"key":"9793_CR40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jmedgenet-2013-102113","volume":"51","author":"VA Cuddapah","year":"2014","unstructured":"Cuddapah VA, Pillai RB, Shekar KV et al (2014) Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. J Med Genet 51:152\u2013158. \n                    https:\/\/doi.org\/10.1136\/jmedgenet-2013-102113","journal-title":"J Med Genet"},{"key":"9793_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF02740625","volume":"13","author":"AJ D\u2019Ercole","year":"1996","unstructured":"D\u2019Ercole AJ, Ye P, Calikoglu AS, Gutierrez-Ospina G (1996) The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 13:227\u2013255. \n                    https:\/\/doi.org\/10.1007\/BF02740625","journal-title":"Mol Neurobiol"},{"key":"9793_CR42","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.freeradbiomed.2009.05.016","volume":"47","author":"C Felice De","year":"2009","unstructured":"De Felice C, Ciccoli L, Leoncini S et al (2009) Systemic oxidative stress in classic Rett syndrome. Free Radic Biol Med 47:440\u2013448. \n                    https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.05.016","journal-title":"Free Radic Biol Med"},{"key":"9793_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.301","author":"B Filippis De","year":"2012","unstructured":"De Filippis B, Fabbri A, Simone D et al (2012) Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of rett syndrome. Neuropsychopharmacology. \n                    https:\/\/doi.org\/10.1038\/npp.2011.301","journal-title":"Neuropsychopharmacology"},{"key":"9793_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2012.05.048","author":"B Filippis De","year":"2013","unstructured":"De Filippis B, Ricceri L, Fuso A, Laviola G (2013) Neonatal exposure to low dose corticosterone persistently modulates hippocampal mineralocorticoid receptor expression and improves locomotor\/exploratory behaviour in a mouse model of Rett syndrome. Neuropharmacology. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2012.05.048","journal-title":"Neuropharmacology"},{"key":"9793_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nbd.2014.04.006","volume":"68","author":"C Felice De","year":"2014","unstructured":"De Felice C, Della Ragione F, Signorini C et al (2014) Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome. Neurobiol Dis 68:66\u201377. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2014.04.006","journal-title":"Neurobiol Dis"},{"key":"9793_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.105","author":"B Filippis De","year":"2014","unstructured":"De Filippis B, Nativio P, Fabbri A et al (2014) Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for rett syndrome. Neuropsychopharmacology. \n                    https:\/\/doi.org\/10.1038\/npp.2014.105","journal-title":"Neuropsychopharmacology"},{"key":"9793_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2015.03.012","author":"B Filippis De","year":"2015","unstructured":"De Filippis B, Valenti D, Chiodi V et al (2015) Modulation of Rho GTPases rescues brain mitochondrial dysfunction, cognitive deficits and aberrant synaptic plasticity in female mice modeling Rett syndrome. Eur Neuropsychopharmacol. \n                    https:\/\/doi.org\/10.1016\/j.euroneuro.2015.03.012","journal-title":"Eur Neuropsychopharmacol"},{"key":"9793_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12017-015-8341-2","volume":"17","author":"RMJ Deacon","year":"2015","unstructured":"Deacon RMJ, Glass L, Snape M et al (2015) NNZ-2566, a novel analog of (1\u20133) IGF-1, as a potential therapeutic agent for Fragile X syndrome. NeuroMol Med 17:71\u201382. \n                    https:\/\/doi.org\/10.1007\/s12017-015-8341-2","journal-title":"NeuroMol Med"},{"key":"9793_CR49","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1101\/gr.118703.110","volume":"21","author":"AM Deaton","year":"2011","unstructured":"Deaton AM, Webb S, Kerr ARW et al (2011) Cell type-specific DNA methylation at intragenic CpG islands in the immune system. Genome Res 21:1074\u20131086. \n                    https:\/\/doi.org\/10.1101\/gr.118703.110","journal-title":"Genome Res"},{"key":"9793_CR50","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/hmg\/ddm007","volume":"16","author":"V Deng","year":"2007","unstructured":"Deng V, Matagne V, Banine F et al (2007) FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum Mol Genet 16:640\u2013650. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddm007","journal-title":"Hum Mol Genet"},{"key":"9793_CR51","doi-asserted-by":"publisher","first-page":"14230","DOI":"10.1073\/pnas.1206093109","volume":"109","author":"R Deogracias","year":"2012","unstructured":"Deogracias R, Yazdani M, Dekkers MP et al (2012) Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome. Proc Natl Acad Sci 109:14230\u201314235","journal-title":"Proc Natl Acad Sci"},{"key":"9793_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/nature10907","author":"NC Derecki","year":"2012","unstructured":"Derecki NC, Cronk JC, Lu Z et al (2012) Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature. \n                    https:\/\/doi.org\/10.1038\/nature10907","journal-title":"Nature"},{"key":"9793_CR53","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0387-7604(93)90045-A","volume":"15","author":"MT Dotti","year":"1993","unstructured":"Dotti MT, Manneschi L, Malandrini A et al (1993) Mitochondrial dysfunction in Rett syndrome an ultrastructural and biochemical study. Brain Dev 15:103\u2013106. \n                    https:\/\/doi.org\/10.1016\/0387-7604(93)90045-A","journal-title":"Brain Dev"},{"key":"9793_CR54","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1073\/pnas.0711795105","volume":"105","author":"M Du","year":"2008","unstructured":"Du M, Liu X, Welch EM et al (2008) PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model. Proc Natl Acad Sci 105:2064\u20132069. \n                    https:\/\/doi.org\/10.1073\/pnas.0711795105","journal-title":"Proc Natl Acad Sci"},{"key":"9793_CR55","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nature12348","volume":"499","author":"DH Ebert","year":"2013","unstructured":"Ebert DH, Gabel HW, Robinson ND et al (2013) Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR. Nature 499:341\u2013345. \n                    https:\/\/doi.org\/10.1038\/nature12348","journal-title":"Nature"},{"key":"9793_CR56","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0387-7604(88)80010-X","volume":"10","author":"O Eeg-Olofsson","year":"1988","unstructured":"Eeg-Olofsson O, Al-Zuhair AG, Teebi AS, Al-Essa MM (1988) Abnormal mitochondria in the Rett syndrome. Brain Dev 10:260\u2013262. \n                    https:\/\/doi.org\/10.1016\/S0387-7604(88)80010-X","journal-title":"Brain Dev"},{"key":"9793_CR57","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1016\/j.braindev.2005.03.020","volume":"27","author":"C Elefant","year":"2005","unstructured":"Elefant C, Wigram T (2005) Learning ability in children with Rett syndrome. Brain Dev 27:S97\u2013S101","journal-title":"Brain Dev"},{"key":"9793_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092169","author":"R El-Khoury","year":"2014","unstructured":"El-Khoury R, Panayotis N, Matagne V et al (2014) GABA and glutamate pathways are spatially and developmentally affected in the brain of Mecp2-deficient mice. PLoS One. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0092169","journal-title":"PLoS One"},{"key":"9793_CR59","first-page":"25","volume":"192","author":"LO Engstrom","year":"1985","unstructured":"Engstrom LO (1985) The National Institutes of Health Small Business Innovation Research (SBIR) Program: opportunities for orphan drug development. Prog Clin Biol Res 192:25\u201330","journal-title":"Prog Clin Biol Res"},{"key":"9793_CR60","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust KD, Nurre E, Montgomery CL et al (2009) Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27:59\u201365. \n                    https:\/\/doi.org\/10.1038\/nbt.1515","journal-title":"Nat Biotechnol"},{"key":"9793_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20110648","volume":"439","author":"KKE Gadalla","year":"2011","unstructured":"Gadalla KKE, Bailey MES, Cobb SR (2011) MeCP2 and Rett syndrome: reversibility and potential avenues for therapy. Biochem J 439:1\u201314. \n                    https:\/\/doi.org\/10.1042\/BJ20110648","journal-title":"Biochem J"},{"key":"9793_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mt.2012.200","volume":"21","author":"KK Gadalla","year":"2013","unstructured":"Gadalla KK, Bailey ME, Spike RC et al (2013) Improved survival and reduced phenotypic severity following AAV9\/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice. Mol Ther 21:18\u201330. \n                    https:\/\/doi.org\/10.1038\/mt.2012.200","journal-title":"Mol Ther"},{"key":"9793_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2017.04.007","author":"KKE Gadalla","year":"2017","unstructured":"Gadalla KKE, Vudhironarit T, Hector RD et al (2017) Development of a novel AAV gene therapy cassette with improved safety features and efficacy in a mouse model of Rett syndrome. Mol Ther-Methods Clin Dev. \n                    https:\/\/doi.org\/10.1016\/j.omtm.2017.04.007","journal-title":"Mol Ther-Methods Clin Dev"},{"key":"9793_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1412-2","author":"A Gandaglia","year":"2018","unstructured":"Gandaglia A, Brivio E, Carli S et al (2018) A novel Mecp2 Y120D knock-in model displays similar behavioral traits but distinct molecular features compared to the Mecp2-null mouse implying precision medicine for the treatment of Rett syndrome. Mol Neurobiol. \n                    https:\/\/doi.org\/10.1007\/s12035-018-1412-2","journal-title":"Mol Neurobiol"},{"key":"9793_CR65","doi-asserted-by":"publisher","first-page":"13612","DOI":"10.1523\/JNEUROSCI.1854-13.2013","volume":"33","author":"SK Garg","year":"2013","unstructured":"Garg SK, Lioy DT, Cheval H et al (2013) Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome. J Neurosci 33:13612\u201313620. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1854-13.2013","journal-title":"J Neurosci"},{"key":"9793_CR66","doi-asserted-by":"publisher","DOI":"10.5493\/wjem.v6.i2.37","author":"A Geisler","year":"2016","unstructured":"Geisler A, Fechner H (2016) MicroRNA-regulated viral vectors for gene therapy. World J Exp Med. \n                    https:\/\/doi.org\/10.5493\/wjem.v6.i2.37","journal-title":"World J Exp Med"},{"key":"9793_CR67","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nn.2997","volume":"15","author":"D Goffin","year":"2011","unstructured":"Goffin D, Allen M, Zhang L et al (2011) Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat Neurosci 15:274\u2013283. \n                    https:\/\/doi.org\/10.1038\/nn.2997","journal-title":"Nat Neurosci"},{"key":"9793_CR68","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s11515-012-1248-5","volume":"7","author":"D Goffin","year":"2012","unstructured":"Goffin D, Zhou Z (Joe) (2012) The neural circuit basis of Rett syndrome. Front Biol (Beijing). 7:428\u2013435","journal-title":"Front Biol (Beijing)"},{"key":"9793_CR69","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw074","author":"RG Gogliotti","year":"2016","unstructured":"Gogliotti RG, Senter RK, Rook JM et al (2016) MGlu5positive allosteric modulation normalizes synaptic plasticity defects and motor phenotypes in a mouse model of Rett syndrome. Hum Mol Genet doi. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddw074","journal-title":"Hum Mol Genet doi"},{"key":"9793_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aai7459","author":"RG Gogliotti","year":"2017","unstructured":"Gogliotti RG, Senter RK, Fisher NM et al (2017) MGlu7potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndrome. Sci Transl Med. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.aai7459","journal-title":"Sci Transl Med"},{"key":"9793_CR71","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mito.2014.02.012","volume":"15","author":"WA Gold","year":"2014","unstructured":"Gold WA, Williamson SL, Kaur S et al (2014) Mitochondrial dysfunction in the skeletal muscle of a mouse model of Rett syndrome (RTT): implications for the disease phenotype. Mitochondrion 15:10\u201317. \n                    https:\/\/doi.org\/10.1016\/j.mito.2014.02.012","journal-title":"Mitochondrion"},{"key":"9793_CR72","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1743-422X-2-43","volume":"2","author":"MA Gon\u00e7alves","year":"2005","unstructured":"Gon\u00e7alves MAFV (2005) Adeno-associated virus: from defective virus to effective vector. Virol J 2:43","journal-title":"Virol J"},{"key":"9793_CR73","doi-asserted-by":"publisher","DOI":"10.2174\/1566523215666150929110424","author":"C Gopinath","year":"2015","unstructured":"Gopinath C, Nathar T, Ghosh A et al (2015) Contemporary animal models for human gene therapy applications. Curr Gene Ther. \n                    https:\/\/doi.org\/10.2174\/1566523215666150929110424","journal-title":"Curr Gene Ther"},{"key":"9793_CR74","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.nbd.2012.06.007","volume":"48","author":"E Gro\u00dfer","year":"2012","unstructured":"Gro\u00dfer E, Hirt U, Janc OA et al (2012) Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome. Neurobiol Dis 48:102\u2013114. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2012.06.007","journal-title":"Neurobiol Dis"},{"key":"9793_CR75","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.exer.2008.05.016","volume":"87","author":"K Guerin","year":"2008","unstructured":"Guerin K, Gregory-Evans CY, Hodges MD et al (2008) Systemic aminoglycoside treatment in rodent models of retinitis pigmentosa. Exp Eye Res 87:197\u2013207. \n                    https:\/\/doi.org\/10.1016\/j.exer.2008.05.016","journal-title":"Exp Eye Res"},{"key":"9793_CR76","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/85899","volume":"27","author":"J Guy","year":"2001","unstructured":"Guy J, Hendrich B, Holmes M et al (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27:322\u2013326. \n                    https:\/\/doi.org\/10.1038\/85899","journal-title":"Nat Genet"},{"key":"9793_CR77","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","volume":"315","author":"J Guy","year":"2007","unstructured":"Guy J, Gan J, Selfridge J et al (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science 315:1143\u20131147. \n                    https:\/\/doi.org\/10.1126\/science.1138389","journal-title":"Science"},{"key":"9793_CR78","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1146\/annurev-cellbio-092910-154121","volume":"27","author":"J Guy","year":"2011","unstructured":"Guy J, Cheval H, Selfridge J, Bird A (2011) The role of MeCP2 in the brain. Annu Rev Cell Dev Biol 27:631\u2013652. \n                    https:\/\/doi.org\/10.1146\/annurev-cellbio-092910-154121","journal-title":"Annu Rev Cell Dev Biol"},{"key":"9793_CR79","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1177\/0883073888003001S02","volume":"3","author":"RH Haas","year":"1988","unstructured":"Haas RH (1988) The history and challenge of Rett syndrome. J Child Neurol 3:S3\u2013S5. \n                    https:\/\/doi.org\/10.1177\/088307388800300102","journal-title":"J Child Neurol"},{"key":"9793_CR80","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1055\/s-2007-979735","volume":"26","author":"RH Haas","year":"1995","unstructured":"Haas RH, Nasirian F, Hua X et al (1995) Oxidative metabolism in Rett syndrome: 2\u2014biochemical and molecular studies. Neuropediatrics 26:95\u201399. \n                    https:\/\/doi.org\/10.1055\/s-2007-979735","journal-title":"Neuropediatrics"},{"key":"9793_CR81","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0022-3476(97)70113-6","volume":"131","author":"RH Haas","year":"1997","unstructured":"Haas RH, Dixon SD, Sartoris DJ, Hannessy MJ (1997) Osteopenia in Rett syndrome. J Pediatr 131:771\u2013774. \n                    https:\/\/doi.org\/10.1016\/S0022-3476(97)70113-6","journal-title":"J Pediatr"},{"key":"9793_CR82","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/mrdd.10020","volume":"8","author":"B Hagberg","year":"2002","unstructured":"Hagberg B (2002) Clinical manifestations and stages of Rett syndrome. Ment Retard Dev Disabil Res Rev 8:61\u201365. \n                    https:\/\/doi.org\/10.1002\/mrdd.10020","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"9793_CR83","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ajmg.1320250506","volume":"1","author":"B Hagberg","year":"1986","unstructured":"Hagberg B, Witt-Engerstr\u00f6m I (1986) Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence. Am J Med Genet 1:47\u201359","journal-title":"Am J Med Genet"},{"key":"9793_CR84","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ana.410140412","volume":"14","author":"B Hagberg","year":"1983","unstructured":"Hagberg B, Aicardi J, Dias K, Ramos O (1983) A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett\u2019s syndrome: report of 35 cases. Ann Neurol 14:471\u2013479. \n                    https:\/\/doi.org\/10.1002\/ana.410140412","journal-title":"Ann Neurol"},{"key":"9793_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/nature15694","author":"S Hao","year":"2015","unstructured":"Hao S, Tang B, Wu Z et al (2015) Forniceal deep brain stimulation rescues hippocampal memory in Rett syndrome mice. Nature. \n                    https:\/\/doi.org\/10.1038\/nature15694","journal-title":"Nature"},{"key":"9793_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep11204","volume":"5","author":"M Hara","year":"2015","unstructured":"Hara M, Takahashi T, Mitsumasu C et al (2015) Disturbance of cardiac gene expression and cardiomyocyte structure predisposes Mecp2-null mice to arrhythmias. Sci Rep 5:1\u201317. \n                    https:\/\/doi.org\/10.1038\/srep11204","journal-title":"Sci Rep"},{"key":"9793_CR87","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0168-9525(03)00080-5","volume":"19","author":"B Hendrich","year":"2003","unstructured":"Hendrich B, Tweedie S (2003) The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet 19:269\u2013277","journal-title":"Trends Genet"},{"key":"9793_CR88","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2018.015","author":"C Hinderer","year":"2018","unstructured":"Hinderer C, Katz N, Buza EL et al (2018) Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an AAV vector expressing human SMN. Hum Gene Ther. \n                    https:\/\/doi.org\/10.1089\/hum.2018.015","journal-title":"Hum Gene Ther"},{"key":"9793_CR89","volume-title":"Brain and development","author":"T Ishii","year":"2001","unstructured":"Ishii T, Makita Y, Ogawa A et al (2001) The role of different X-inactivation pattern on the variable clinical phenotype with Rett syndrome. In: Brain and development. Elsevier, Amsterdam, pp\u00a0161\u2013164"},{"key":"9793_CR90","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/nen.0b013e3180302078","volume":"66","author":"M Itoh","year":"2007","unstructured":"Itoh M, Ide S, Takashima S et al (2007) Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains. J Neuropathol Exp Neurol 66:117\u2013123. \n                    https:\/\/doi.org\/10.1097\/nen.0b013e3180302078","journal-title":"J Neuropathol Exp Neurol"},{"key":"9793_CR91","doi-asserted-by":"publisher","first-page":"13859","DOI":"10.1074\/jbc.M111.309864","volume":"287","author":"M Itoh","year":"2012","unstructured":"Itoh M, Tahimic CGT, Ide S et al (2012) Methyl CpG-binding protein isoform MeCP2-e2 is dispensable for Rett syndrome phenotypes but essential for embryo viability and placenta development. J Biol Chem 287:13859\u201313867. \n                    https:\/\/doi.org\/10.1074\/jbc.M111.309864","journal-title":"J Biol Chem"},{"key":"9793_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2016.00266","author":"OA Janc","year":"2016","unstructured":"Janc OA, H\u00fcser MA, Dietrich K et al (2016) Systemic radical scavenger treatment of a mouse model of Rett syndrome: merits and limitations of the vitamin E derivative trolox. Front Cell Neurosci. \n                    https:\/\/doi.org\/10.3389\/fncel.2016.00266","journal-title":"Front Cell Neurosci"},{"key":"9793_CR93","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2202-11-19","volume":"11","author":"GM Jentarra","year":"2010","unstructured":"Jentarra GM, Olfers SL, Rice SG et al (2010) Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome\/X-linked mental retardation. BMC Neurosci 11:19. \n                    https:\/\/doi.org\/10.1186\/1471-2202-11-19","journal-title":"BMC Neurosci"},{"key":"9793_CR94","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01361.2011","author":"RA Johnson","year":"2012","unstructured":"Johnson RA, Lam M, Punzo AM et al (2012) 7,8-dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome. J Appl Physiol. \n                    https:\/\/doi.org\/10.1152\/japplphysiol.01361.2011","journal-title":"J Appl Physiol"},{"key":"9793_CR95","doi-asserted-by":"publisher","first-page":"e27265","DOI":"10.4161\/rdis.27265","volume":"1","author":"MJ Justice","year":"2013","unstructured":"Justice MJ, Buchovecky CM, Kyle SM, Djukic A (2013) A role for metabolism in Rett syndrome pathogenesis: new clinical findings and potential treatment targets. Rare Dis 1:e27265. \n                    https:\/\/doi.org\/10.4161\/rdis.27265","journal-title":"Rare Dis"},{"key":"9793_CR96","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.biopsych.2016.03.1045","volume":"79","author":"DM Katz","year":"2016","unstructured":"Katz DM, Menniti FS, Mather RJ (2016) N-methyl-D-aspartate receptors, ketamine, and Rett syndrome: something special on the road to treatments? Biol Psychiatry 79:710\u2013712","journal-title":"Biol Psychiatry"},{"key":"9793_CR97","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-genom-091212-153527","volume":"15","author":"KM Keeling","year":"2014","unstructured":"Keeling KM, Xue X, Gunn G, Bedwell DM (2014) Therapeutics based on stop codon readthrough. Annu Rev Genom Hum Genet 15:371\u2013394. \n                    https:\/\/doi.org\/10.1146\/annurev-genom-091212-153527","journal-title":"Annu Rev Genom Hum Genet"},{"key":"9793_CR98","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S2213-2600(14)70100-6","volume":"2","author":"E Kerem","year":"2014","unstructured":"Kerem E, Konstan MW, De Boeck K et al (2014) Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Respir Med 2:539\u2013547. \n                    https:\/\/doi.org\/10.1016\/S2213-2600(14)70100-6","journal-title":"Lancet Respir Med"},{"key":"9793_CR99","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.1073\/pnas.1311141111","volume":"111","author":"OS Khwaja","year":"2014","unstructured":"Khwaja OS, Ho E, Barnes KV et al (2014) Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome. Proc Natl Acad Sci 111:4596\u20134601. \n                    https:\/\/doi.org\/10.1073\/pnas.1311141111","journal-title":"Proc Natl Acad Sci"},{"key":"9793_CR100","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.mcn.2004.07.006","volume":"27","author":"N Kishi","year":"2004","unstructured":"Kishi N, Macklis JD (2004) MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 27:306\u2013321. \n                    https:\/\/doi.org\/10.1016\/j.mcn.2004.07.006","journal-title":"Mol Cell Neurosci"},{"key":"9793_CR101","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/sj.ejhg.5201682","volume":"14","author":"GPS Knudsen","year":"2006","unstructured":"Knudsen GPS, Neilson TCS, Pedersen J et al (2006) Increased skewing of X chromosome inactivation in Rett syndrome patients and their mothers. Eur J Hum Genet 14:1189\u20131194. \n                    https:\/\/doi.org\/10.1038\/sj.ejhg.5201682","journal-title":"Eur J Hum Genet"},{"key":"9793_CR102","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1101\/gad.320325.118","volume":"32","author":"MV Koerner","year":"2018","unstructured":"Koerner MV, FitzPatrick L, Selfridge J et al (2018) Toxicity of overexpressed MeCP2 is independent of HDAC3 activity. Genes Dev 32:1514\u20131524","journal-title":"Genes Dev"},{"key":"9793_CR103","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2008.06305.x","author":"M Kondo","year":"2008","unstructured":"Kondo M, Gray LJ, Pelka GJ et al (2008) Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome\u2014Mecp2 gene dosage effects and BDNF expression. Eur J Neurosci. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06305.x","journal-title":"Eur J Neurosci"},{"key":"9793_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/dneu.22308","author":"MA Kondo","year":"2016","unstructured":"Kondo MA, Gray LJ, Pelka GJ et al (2016) Affective dysfunction in a mouse model of Rett syndrome: therapeutic effects of environmental stimulation and physical activity. Dev Neurobiol. \n                    https:\/\/doi.org\/10.1002\/dneu.22308","journal-title":"Dev Neurobiol"},{"key":"9793_CR105","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1128\/MCB.01665-05","volume":"26","author":"S Kriaucionis","year":"2006","unstructured":"Kriaucionis S, Paterson A, Curtis J et al (2006) Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol Cell Biol 26:5033\u20135042. \n                    https:\/\/doi.org\/10.1128\/MCB.01665-05","journal-title":"Mol Cell Biol"},{"key":"9793_CR106","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1172\/JCI80323","volume":"125","author":"N Krishnan","year":"2015","unstructured":"Krishnan N, Krishnan K, Connors CR et al (2015) PTP1B inhibition suggests a therapeutic strategy for Rett syndrome. J Clin Invest 125:3163\u20133177. \n                    https:\/\/doi.org\/10.1172\/JCI80323","journal-title":"J Clin Invest"},{"key":"9793_CR107","doi-asserted-by":"publisher","first-page":"13860","DOI":"10.1523\/JNEUROSCI.2159-12.2012","volume":"32","author":"M Kron","year":"2012","unstructured":"Kron M, Howell CJ, Adams IT et al (2012) Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment. J Neurosci 32:13860\u201313872. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.2159-12.2012","journal-title":"J Neurosci"},{"key":"9793_CR108","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1242\/dmm.016030","volume":"7","author":"M Kron","year":"2014","unstructured":"Kron M, Lang M, Adams IT et al (2014) A BDNF loop-domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome. Dis Model Mech 7:1047\u20131055. \n                    https:\/\/doi.org\/10.1242\/dmm.016030","journal-title":"Dis Model Mech"},{"key":"9793_CR109","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pediatrneurol.2017.01.010","volume":"70","author":"A Kumar","year":"2017","unstructured":"Kumar A, Jaryal A, Gulati S et al (2017) Cardiovascular autonomic dysfunction in children and adolescents with Rett syndrome. Pediatr Neurol 70:61\u201366. \n                    https:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.01.010","journal-title":"Pediatr Neurol"},{"key":"9793_CR110","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/17469899.2018.1429916","volume":"13","author":"N Kumaran","year":"2018","unstructured":"Kumaran N, Smith AJ, Michaelides M et al (2018) Gene therapy for leber congenital amaurosis. Expert Rev Ophthalmol 13:11\u201315","journal-title":"Expert Rev Ophthalmol"},{"key":"9793_CR111","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molmed.2006.05.005","volume":"12","author":"HA Kuzmiak","year":"2006","unstructured":"Kuzmiak HA, Maquat LE (2006) Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges. Trends Mol Med 12:306\u2013316","journal-title":"Trends Mol Med"},{"key":"9793_CR112","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1093\/hmg\/ddw156","volume":"25","author":"SM Kyle","year":"2016","unstructured":"Kyle SM, Saha PK, Brown HM et al (2016) MeCP2 co-ordinates liver lipid metabolism with the NCoR1\/HDAC3 corepressor complex. Hum Mol Genet 25:3029\u20133041. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddw156","journal-title":"Hum Mol Genet"},{"key":"9793_CR113","doi-asserted-by":"publisher","first-page":"170216","DOI":"10.1098\/rsob.170216","volume":"8","author":"SM Kyle","year":"2018","unstructured":"Kyle SM, Vashi N, Justice MJ (2018) Rett syndrome: a neurological disorder with metabolic components. Open Biol 8:170216. \n                    https:\/\/doi.org\/10.1098\/rsob.170216","journal-title":"Open Biol"},{"key":"9793_CR114","doi-asserted-by":"publisher","first-page":"252259","DOI":"10.1016\/j.brainresrev.2011.02.005","volume":"67","author":"R Lalonde","year":"2011","unstructured":"Lalonde R, Strazielle C (2011) Brain regions and genes affecting limb-clasping responses. Brain Res. Rev 67:252\u2013259","journal-title":"Brain Res. Rev"},{"key":"9793_CR115","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jpeds.2005.10.037","volume":"148","author":"CL Laurvick","year":"2006","unstructured":"Laurvick CL, de Klerk N, Bower C et al (2006) Rett syndrome in Australia: a review of the epidemiology. J Pediatr 148:347\u2013352. \n                    https:\/\/doi.org\/10.1016\/j.jpeds.2005.10.037","journal-title":"J Pediatr"},{"key":"9793_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2007.08.039","volume":"1180","author":"A Lawson-Yuen","year":"2007","unstructured":"Lawson-Yuen A, Liu D, Han L et al (2007) Ube3a mRNA and protein expression are not decreased in Mecp2R168X mutant mice. Brain Res 1180:1\u20136. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2007.08.039","journal-title":"Brain Res"},{"key":"9793_CR117","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1179\/1351000211Y.0000000004","volume":"16","author":"S Leoncini","year":"2011","unstructured":"Leoncini S, De Felice C, Signorini C et al (2011) Oxidative stress in Rett syndrome: natural history, genotype, and variants. Redox Rep 16:145\u2013153. \n                    https:\/\/doi.org\/10.1179\/1351000211Y.0000000004","journal-title":"Redox Rep"},{"key":"9793_CR118","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00889.2013","author":"ES Levitt","year":"2013","unstructured":"Levitt ES, Hunnicutt BJ, Knopp SJ et al (2013) A selective 5-HT 1a receptor agonist improves respiration in a mouse model of Rett syndrome. J Appl Physiol. \n                    https:\/\/doi.org\/10.1152\/japplphysiol.00889.2013","journal-title":"J Appl Physiol"},{"key":"9793_CR119","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0092-8674(92)90610-O","volume":"69","author":"JD Lewis","year":"1992","unstructured":"Lewis JD, Meehan RR, Henzel WJ et al (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNA. Cell 69:905\u2013914. \n                    https:\/\/doi.org\/10.1016\/0092-8674(92)90610-O","journal-title":"Cell"},{"key":"9793_CR120","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.029959","author":"W Li","year":"2017","unstructured":"Li W, Bellot-Saez A, Phillips ML et al (2017) A small-molecule TrkB ligand restores hippocampal synaptic plasticity and object location memory in Rett syndrome mice. Dis Model Mech. \n                    https:\/\/doi.org\/10.1242\/dmm.029959","journal-title":"Dis Model Mech"},{"key":"9793_CR121","doi-asserted-by":"publisher","first-page":"158","DOI":"10.5582\/irdr.2016.01045","volume":"5","author":"A Ligsay","year":"2016","unstructured":"Ligsay A, Hagerman RJ (2016) Review of targeted treatments in fragile X syndrome. Intractable Rare Dis Res 5:158\u2013167","journal-title":"Intractable Rare Dis Res"},{"key":"9793_CR122","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28523","author":"L Linde","year":"2007","unstructured":"Linde L, Boelz S, Nissim-Rafinia M et al (2007) Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin. J Clin Invest. \n                    https:\/\/doi.org\/10.1172\/JCI28523","journal-title":"J Clin Invest"},{"key":"9793_CR123","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nature10214","volume":"475","author":"DT Lioy","year":"2011","unstructured":"Lioy DT, Garg SK, Monaghan CE et al (2011) A role for glia in the progression of Rett\u2019s syndrome. Nature 475:497\u2013500. \n                    https:\/\/doi.org\/10.1038\/nature10214","journal-title":"Nature"},{"key":"9793_CR124","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1177\/0961203313496340","volume":"22","author":"K Liu","year":"2013","unstructured":"Liu K, Zhang L, Chen J et al (2013) Association of MeCP2 (rs2075596, rs2239464) genetic polymorphisms with systemic lupus erythematosus: a meta-analysis. Lupus 22:908\u2013918. \n                    https:\/\/doi.org\/10.1177\/0961203313496340","journal-title":"Lupus"},{"key":"9793_CR125","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.stem.2014.01.018","volume":"14","author":"H Liu","year":"2014","unstructured":"Liu H, Chen Y, Niu Y et al (2014) TALEN-mediated gene mutagenesis in rhesus and cynomolgus monkeys. Cell Stem Cell 14:323\u2013328. \n                    https:\/\/doi.org\/10.1016\/j.stem.2014.01.018","journal-title":"Cell Stem Cell"},{"key":"9793_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.12.022","author":"G Lonetti","year":"2010","unstructured":"Lonetti G, Angelucci A, Morando L et al (2010) Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 Null mice. Biol Psychiatry. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2009.12.022","journal-title":"Biol Psychiatry"},{"key":"9793_CR127","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrg3897","volume":"16","author":"MJ Lyst","year":"2015","unstructured":"Lyst MJ, Bird A (2015) Rett syndrome: a complex disorder with simple roots. Nat Rev Genet 16:261\u2013275. \n                    https:\/\/doi.org\/10.1038\/nrg3897","journal-title":"Nat Rev Genet"},{"key":"9793_CR128","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/nn.3434","volume":"16","author":"MJ Lyst","year":"2013","unstructured":"Lyst MJ, Ekiert R, Ebert DH et al (2013) Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR\/SMRT co-repressor. Nat Neurosci 16:898\u2013902. \n                    https:\/\/doi.org\/10.1038\/nn.3434","journal-title":"Nat Neurosci"},{"key":"9793_CR129","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.468","author":"J Mancini","year":"2018","unstructured":"Mancini J, Dubus JC, Jouve E et al (2018) Effect of desipramine on patients with breathing disorders in RETT syndrome. Ann Clin Transl Neurol. \n                    https:\/\/doi.org\/10.1002\/acn3.468","journal-title":"Ann Clin Transl Neurol"},{"key":"9793_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2009.02.038","author":"JG Mantis","year":"2009","unstructured":"Mantis JG, Fritz CL, Marsh J et al (2009) Improvement in motor and exploratory behavior in Rett syndrome mice with restricted ketogenic and standard diets. Epilepsy Behav. \n                    https:\/\/doi.org\/10.1016\/j.yebeh.2009.02.038","journal-title":"Epilepsy Behav"},{"key":"9793_CR131","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","volume":"8","author":"DM McCarty","year":"2001","unstructured":"McCarty DM, Monahan PE, Samulski RJ (2001) Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther 8:1248\u20131254. \n                    https:\/\/doi.org\/10.1038\/sj.gt.3301514","journal-title":"Gene Ther"},{"key":"9793_CR132","doi-asserted-by":"publisher","first-page":"113ra125","DOI":"10.1126\/scitranslmed.3002982","volume":"3","author":"MD McCauley","year":"2011","unstructured":"McCauley MD, Wang T, Mike E et al (2011) Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome. Sci Transl Med 3:113ra125\u2013113ra125. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.3002982","journal-title":"Sci Transl Med"},{"key":"9793_CR133","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","volume":"390","author":"CM McDonald","year":"2017","unstructured":"McDonald CM, Campbell C, Torricelli RE et al (2017) Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 390:1489\u20131498. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(17)31611-2","journal-title":"Lancet"},{"key":"9793_CR134","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1309426111","author":"N Mellios","year":"2014","unstructured":"Mellios N, Woodson J, Garcia RI et al (2014) \u03b22-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome. Proc Natl Acad Sci. \n                    https:\/\/doi.org\/10.1073\/pnas.1309426111","journal-title":"Proc Natl Acad Sci"},{"key":"9793_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s13072-015-0034-4","author":"A Minkovsky","year":"2015","unstructured":"Minkovsky A, Sahakyan A, Bonora G et al (2015) A high-throughput screen of inactive X chromosome reactivation identifies the enhancement of DNA demethylation by 5-aza-2\u2032-dC upon inhibition of ribonucleotide reductase. Epigenet Chromatin. \n                    https:\/\/doi.org\/10.1186\/s13072-015-0034-4","journal-title":"Epigenet Chromatin"},{"key":"9793_CR136","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ymgme.2004.09.007","volume":"84","author":"F Mochel","year":"2005","unstructured":"Mochel F, DeLonlay P, Touati G et al (2005) Pyruvate carboxylase deficiency: Clinical and biochemical response to anaplerotic diet therapy. Mol Genet Metab 84:305\u2013312. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2004.09.007","journal-title":"Mol Genet Metab"},{"key":"9793_CR137","doi-asserted-by":"publisher","first-page":"60306","DOI":"10.1002\/cpt.1181","volume":"104","author":"ME Modi","year":"2018","unstructured":"Modi ME, Sahin M (2018) The way forward for mechanism-based therapeutics in genetically defined neurodevelopmental disorders. Clin Pharmacol Ther 104:603\u201306","journal-title":"Clin Pharmacol Ther"},{"key":"9793_CR138","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2623-05.2006","author":"P Moretti","year":"2006","unstructured":"Moretti P (2006) Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J Neurosci. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.2623-05.2006","journal-title":"J Neurosci"},{"key":"9793_CR139","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd.2017.244","volume":"17","author":"P Morgan","year":"2018","unstructured":"Morgan P, Brown DG, Lennard S et al (2018) Impact of a five-dimensional framework on R&D productivity at AstraZeneca. Nat Rev Drug Discov 17:167","journal-title":"Nat Rev Drug Discov"},{"key":"9793_CR140","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/MPG.0b013e31824b6159","volume":"55","author":"KJ Motil","year":"2012","unstructured":"Motil KJ, Caeg E, Barrish JO et al (2012) Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome. J Pediatr Gastroenterol Nutr 55:292\u2013298. \n                    https:\/\/doi.org\/10.1097\/MPG.0b013e31824b6159","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"9793_CR141","doi-asserted-by":"publisher","DOI":"10.1111\/1469-7610.00236","author":"RH Mount","year":"2002","unstructured":"Mount RH, Charman T, Hastings RP et al (2002) The Rett syndrome behaviour questionnaire (RSBQ): refining the behavioural phenotype of Rett syndrome. J Child Psychol Psychiatry Allied Discip. \n                    https:\/\/doi.org\/10.1111\/1469-7610.00236","journal-title":"J Child Psychol Psychiatry Allied Discip"},{"key":"9793_CR142","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183026","author":"ES Na","year":"2017","unstructured":"Na ES, De Jes\u00fas-Cort\u00e9s H, Martinez-Rivera A et al (2017) D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome. PLoS ONE. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0183026","journal-title":"PLoS ONE"},{"key":"9793_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2007.02.003","author":"N Nag","year":"2007","unstructured":"Nag N, Berger-Sweeney JE (2007) Postnatal dietary choline supplementation alters behavior in a mouse model of Rett syndrome. Neurobiol Dis. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2007.02.003","journal-title":"Neurobiol Dis"},{"key":"9793_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2008.07.008","author":"N Nag","year":"2009","unstructured":"Nag N, Moriuchi JM, Peitzman CGK et al (2009) Environmental enrichment alters locomotor behaviour and ventricular volume in Mecp21lox mice. Behav Brain Res. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2008.07.008","journal-title":"Behav Brain Res"},{"key":"9793_CR145","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s40259-016-0157-6","volume":"30","author":"K Nagel-Wolfrum","year":"2016","unstructured":"Nagel-Wolfrum K, M\u00f6ller F, Penner I et al (2016) Targeting nonsense mutations in diseases with translational read-through-inducing drugs (TRIDs). BioDrugs 30:49\u201374. \n                    https:\/\/doi.org\/10.1007\/s40259-016-0157-6","journal-title":"BioDrugs"},{"key":"9793_CR146","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0968-0004(98)01208-0","volume":"6","author":"E Nagy","year":"1998","unstructured":"Nagy E, Maquat LE (1998) A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci 6:198\u2013199","journal-title":"Trends Biochem Sci"},{"key":"9793_CR147","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0092-8674(00)81887-5","volume":"88","author":"X Nan","year":"1997","unstructured":"Nan X, Campoy FJ, Bird A (1997) MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88:471\u2013481","journal-title":"Cell"},{"key":"9793_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-1004-5","author":"E Nance","year":"2017","unstructured":"Nance E, Kambhampati SP, Smith ES et al (2017) Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome. J Neuroinflamm. \n                    https:\/\/doi.org\/10.1186\/s12974-017-1004-5","journal-title":"J Neuroinflamm"},{"key":"9793_CR149","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","volume":"70","author":"JL Neul","year":"2008","unstructured":"Neul JL, Fang P, Barrish J et al (2008) Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology 70:1313\u20131321. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000291011.54508.aa","journal-title":"Neurology"},{"key":"9793_CR150","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neubiorev.2013.10.016","volume":"46","author":"LS Nguyen","year":"2014","unstructured":"Nguyen LS, Wilkinson MF, Gecz J (2014) Nonsense-mediated mRNA decay: inter-individual variability and human disease. Neurosci Biobehav Rev 46:175\u2013186","journal-title":"Neurosci Biobehav Rev"},{"key":"9793_CR151","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/acn3.533","volume":"5","author":"HM O\u2019Leary","year":"2018","unstructured":"O\u2019Leary HM, Kaufmann WE, Barnes KV et al (2018) Placebo-controlled crossover assessment of mecasermin for the treatment of Rett syndrome. Ann Clin Transl Neurol 5:323\u2013332. \n                    https:\/\/doi.org\/10.1002\/acn3.533","journal-title":"Ann Clin Transl Neurol"},{"key":"9793_CR152","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1869-07.2007","author":"M Ogier","year":"2007","unstructured":"Ogier M, Wang H, Hong E et al (2007) Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. J Neurosci. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1869-07.2007","journal-title":"J Neurosci"},{"key":"9793_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2016.03.016","author":"K Ohno","year":"2016","unstructured":"Ohno K, Saito Y, Ueda R et al (2016) Effect of serotonin 1A agonists and selective serotonin reuptake inhibitors on behavioral and nighttime respiratory symptoms in Rett syndrome. Pediatr Neurol. \n                    https:\/\/doi.org\/10.1016\/j.pediatrneurol.2016.03.016","journal-title":"Pediatr Neurol"},{"key":"9793_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.05.033","author":"LLL Orefice","year":"2016","unstructured":"Orefice LLL, Zimmerman ALL, Chirila AMM et al (2016) Peripheral mechanosensory neuron dysfunction underlies tactile and behavioral deficits in mouse models of ASDs. Cell. \n                    https:\/\/doi.org\/10.1016\/j.cell.2016.05.033","journal-title":"Cell"},{"key":"9793_CR155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064863","author":"A Panighini","year":"2013","unstructured":"Panighini A, Duranti E, Santini F et al (2013) Vascular dysfunction in a mouse model of Rett syndrome and effects of curcumin treatment. PLoS ONE. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0064863","journal-title":"PLoS ONE"},{"key":"9793_CR156","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109527","author":"MJ Park","year":"2014","unstructured":"Park MJ, Aja S, Li Q et al (2014) Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice. PLoS ONE. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0109527","journal-title":"PLoS ONE"},{"key":"9793_CR157","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1097\/01.jnen.0000187054.59018.f2","volume":"64","author":"DS Paterson","year":"2005","unstructured":"Paterson DS, Thompson EG, Belliveau RA et al (2005) Serotonin transporter abnormality in the dorsal motor nucleus of the vagus in rett syndrome: potential implications for clinical autonomic dysfunction. J Neuropathol Exp Neurol 64:1018\u20131027. \n                    https:\/\/doi.org\/10.1097\/01.jnen.0000187054.59018.f2","journal-title":"J Neuropathol Exp Neurol"},{"key":"9793_CR158","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.biopsych.2015.08.018","volume":"79","author":"A Patrizi","year":"2016","unstructured":"Patrizi A, Picard N, Simon AJ et al (2016) Chronic administration of the N-methyl-D-aspartate receptor antagonist ketamine improves Rett syndrome phenotype. Biol Psychiatry 79:755\u2013764. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2015.08.018","journal-title":"Biol Psychiatry"},{"key":"9793_CR159","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl022","author":"GJ Pelka","year":"2006","unstructured":"Pelka GJ, Watson CM, Radziewic T et al (2006) Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain. \n                    https:\/\/doi.org\/10.1093\/brain\/awl022","journal-title":"Brain"},{"key":"9793_CR160","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt111","author":"MR Pitcher","year":"2013","unstructured":"Pitcher MR, Ward CS, Arvide EM et al (2013) Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function. Hum Mol Genet. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddt111","journal-title":"Hum Mol Genet"},{"key":"9793_CR161","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1093\/hmg\/ddv030","volume":"24","author":"MR Pitcher","year":"2015","unstructured":"Pitcher MR, Herrera JA, Buffington SA et al (2015) Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene. Hum Mol Genet 24:2662\u20132672. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddv030","journal-title":"Hum Mol Genet"},{"key":"9793_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-018-0266-3","author":"L Pizzo","year":"2018","unstructured":"Pizzo L, Jensen M, Polyak A et al (2018) Rare variants in the genetic background modulate cognitive and developmental phenotypes in individuals carrying disease-associated variants. Genet Med. \n                    https:\/\/doi.org\/10.1038\/s41436-018-0266-3","journal-title":"Genet Med."},{"key":"9793_CR163","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/jnr.22409","volume":"88","author":"AC Popescu","year":"2010","unstructured":"Popescu AC, Sidorova E, Zhang G, Eubanks JH (2010) Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro. J Neurosci Res 88:2316\u20132324. \n                    https:\/\/doi.org\/10.1002\/jnr.22409","journal-title":"J Neurosci Res"},{"key":"9793_CR164","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nn0403-345","volume":"6","author":"L Puglielli","year":"2003","unstructured":"Puglielli L, Tanzi RE, Kovacs DM (2003) Alzheimer\u2019s disease: the cholesterol connection. Nat Neurosci 6:345\u2013351. \n                    https:\/\/doi.org\/10.1038\/nn0403-345","journal-title":"Nat Neurosci"},{"key":"9793_CR165","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.resp.2013.06.022","volume":"189","author":"JM Ramirez","year":"2013","unstructured":"Ramirez JM, Ward CS, Neul JL (2013) Breathing challenges in Rett Syndrome: lessons learned from humans and animal models. Respir Physiol Neurobiol 189:280\u2013287","journal-title":"Respir Physiol Neurobiol"},{"key":"9793_CR166","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/s41593-018-0270-6","volume":"21","author":"W Renthal","year":"2018","unstructured":"Renthal W, Boxer LD, Hrvatin S et al (2018) Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing. Nat Neurosci 21:1670\u20131679. \n                    https:\/\/doi.org\/10.1038\/s41593-018-0270-6","journal-title":"Nat Neurosci"},{"key":"9793_CR167","first-page":"723","volume":"1946","author":"A Rett","year":"1966","unstructured":"Rett A (1966) On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med Wochenschr 1946:723\u2013726","journal-title":"Wien Med Wochenschr"},{"key":"9793_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2011.03.051","author":"L Ricceri","year":"2011","unstructured":"Ricceri L, De Filippis B, Fuso A, Laviola G (2011) Cholinergic hypofunction in MeCP2-308 mice: beneficial neurobehavioural effects of neonatal choline supplementation. Behav Brain Res. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2011.03.051","journal-title":"Behav Brain Res"},{"key":"9793_CR169","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1172\/JCI0215311","volume":"110","author":"CR Roe","year":"2002","unstructured":"Roe CR, Sweetman L, Roe DS et al (2002) Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J Clin Investig 110:259\u2013269. \n                    https:\/\/doi.org\/10.1172\/JCI0215311","journal-title":"J Clin Investig"},{"key":"9793_CR170","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2007.05466.x","author":"JC Roux","year":"2007","unstructured":"Roux JC, Dura E, Moncla A et al (2007) Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome. Eur J Neurosci. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05466.x","journal-title":"Eur J Neurosci"},{"key":"9793_CR171","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/hmg\/ddn062","volume":"17","author":"RC Samaco","year":"2008","unstructured":"Samaco RC, Fryer JD, Ren J et al (2008) A partial loss of function allele of Methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome. Hum Mol Genet 17:1718\u20131727. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddn062","journal-title":"Hum Mol Genet"},{"key":"9793_CR172","doi-asserted-by":"publisher","DOI":"10.1038\/ng.1066","author":"RC Samaco","year":"2012","unstructured":"Samaco RC, Mandel-Brehm C, McGraw CM et al (2012) Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome. Nat Genet. \n                    https:\/\/doi.org\/10.1038\/ng.1066","journal-title":"Nat Genet"},{"key":"9793_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2010.07.010","author":"M Santos","year":"2010","unstructured":"Santos M, Summavielle T, Teixeira-Castro A et al (2010) Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the involvement of the cerebral cortex in early stages of Rett syndrome. Neuroscience. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2010.07.010","journal-title":"Neuroscience"},{"key":"9793_CR174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051586","author":"LR Schaevitz","year":"2012","unstructured":"Schaevitz LR, Nicolai R, Lopez CM et al (2012) Acetyl-L-carnitine improves behavior and dendritic morphology in a mouse model of Rett syndrome. PLoS ONE. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0051586","journal-title":"PLoS ONE"},{"key":"9793_CR175","doi-asserted-by":"publisher","DOI":"10.1111\/gbb.12070","author":"LR Schaevitz","year":"2013","unstructured":"Schaevitz LR, G\u00f3mez NB, Zhen DP, Berger-Sweeney JE (2013) MeCP2 R168X male and female mutant mice exhibit Rett-like behavioral deficits. Genes, Brain Behav. \n                    https:\/\/doi.org\/10.1111\/gbb.12070","journal-title":"Genes, Brain Behav"},{"key":"9793_CR176","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0865-11.2012","author":"DA Schmid","year":"2012","unstructured":"Schmid DA, Yang T, Ogier M et al (2012) A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome. J Neurosci. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0865-11.2012","journal-title":"J Neurosci"},{"key":"9793_CR177","doi-asserted-by":"publisher","first-page":"303312","DOI":"10.1172\/JCI200317741","volume":"111","author":"EA Schon","year":"2003","unstructured":"Schon EA, Manfredi G (2003) Neuronal degeneration and mitochondrial dysfunction. J Clin Investig 111:303\u2013312","journal-title":"J Clin Investig"},{"key":"9793_CR178","doi-asserted-by":"publisher","first-page":"e104834","DOI":"10.1371\/journal.pone.0104834","volume":"9","author":"M Segatto","year":"2014","unstructured":"Segatto M, Trapani L, Di Tunno I et al (2014) Cholesterol metabolism is altered in Rett syndrome: a study on plasma and primary cultured fibroblasts derived from patients. PLoS ONE 9:e104834. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0104834","journal-title":"PLoS ONE"},{"key":"9793_CR179","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0896-6273(02)00768-7","volume":"35","author":"MD Shahbazian","year":"2002","unstructured":"Shahbazian MD, Young JI, Yuva-Paylor LA et al (2002a) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35:243\u2013254. \n                    https:\/\/doi.org\/10.1016\/S0896-6273(02)00768-7","journal-title":"Neuron"},{"key":"9793_CR180","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/hmg\/11.2.115","volume":"11","author":"MD Shahbazian","year":"2002","unstructured":"Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY (2002b) Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11:115\u2013124. \n                    https:\/\/doi.org\/10.1093\/hmg\/11.2.115","journal-title":"Hum Mol Genet"},{"key":"9793_CR181","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1203\/PDR.0b013e3181f2edd2","volume":"68","author":"JR Shapiro","year":"2010","unstructured":"Shapiro JR, Bibat G, Hiremath G et al (2010) Bone mass in Rett syndrome: association with clinical parameters and MECP2 mutations. Pediatr Res 68:446\u2013451. \n                    https:\/\/doi.org\/10.1203\/PDR.0b013e3181f2edd2","journal-title":"Pediatr Res"},{"key":"9793_CR182","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00058","author":"N Shulyakova","year":"2017","unstructured":"Shulyakova N, Andreazza AC, Mills LR, Eubanks JH (2017) Mitochondrial dysfunction in the pathogenesis of Rett syndrome: implications for mitochondria-targeted therapies. Front Cell Neurosci. \n                    https:\/\/doi.org\/10.3389\/fncel.2017.00058","journal-title":"Front Cell Neurosci"},{"key":"9793_CR183","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.omtm.2017.04.006","volume":"5","author":"SE Sinnett","year":"2017","unstructured":"Sinnett SE, Hector RD, Gadalla KKE et al (2017) Improved MECP2 gene therapy extends the survival of MeCP2-null mice without apparent Toxicity after intracisternal delivery. Mol Ther-Methods Clin Dev 5:106\u2013115. \n                    https:\/\/doi.org\/10.1016\/j.omtm.2017.04.006","journal-title":"Mol Ther-Methods Clin Dev"},{"key":"9793_CR184","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.molcel.2010.01.030","volume":"37","author":"PJ Skene","year":"2010","unstructured":"Skene PJ, Illingworth RS, Webb S et al (2010) Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell 37:457\u2013468. \n                    https:\/\/doi.org\/10.1016\/j.molcel.2010.01.030","journal-title":"Mol Cell"},{"key":"9793_CR185","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1073\/pnas.1621356114","volume":"114","author":"S Sripathy","year":"2017","unstructured":"Sripathy S, Leko V, Adrianse RL et al (2017) Screen for reactivation of MeCP2 on the inactive X chromosome identifies the BMP\/TGF-\u03b2 superfamily as a regulator of XIST expression. Proc Natl Acad Sci 114:1619\u20131624. \n                    https:\/\/doi.org\/10.1073\/pnas.1621356114","journal-title":"Proc Natl Acad Sci"},{"key":"9793_CR186","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.136","author":"K Szczesna","year":"2014","unstructured":"Szczesna K, De La Caridad O, Petazzi P et al (2014) Improvement of the rett syndrome phenotype in a mecp2 mouse model upon treatment with levodopa and a dopa-decarboxylase inhibitor. Neuropsychopharmacology. \n                    https:\/\/doi.org\/10.1038\/npp.2014.136","journal-title":"Neuropsychopharmacology"},{"key":"9793_CR187","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1073\/pnas.0811648106","volume":"106","author":"J Tao","year":"2009","unstructured":"Tao J, Hu K, Chang Q et al (2009) Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. Proc Natl Acad Sci 106:4882\u20134887. \n                    https:\/\/doi.org\/10.1073\/pnas.0811648106","journal-title":"Proc Natl Acad Sci"},{"key":"9793_CR188","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0672-16.2016","author":"J Tao","year":"2016","unstructured":"Tao J, Wu H, Coronado AA et al (2016) Negative allosteric modulation of mGluR5 partially corrects pathophysiology in a mouse model of Rett syndrome. J Neurosci. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0672-16.2016","journal-title":"J Neurosci"},{"key":"9793_CR189","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/ng0296-205","volume":"12","author":"P Tate","year":"1996","unstructured":"Tate P, Skarnes W, Bird A (1996) The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nat Genet 12:205\u2013208. \n                    https:\/\/doi.org\/10.1038\/ng0296-205","journal-title":"Nat Genet"},{"key":"9793_CR190","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nature24058","volume":"550","author":"R Tillotson","year":"2017","unstructured":"Tillotson R, Selfridge J, Koerner MV et al (2017) Radically truncated MeCP2 rescues Rett syndrome-like neurological defects. Nature 550:398\u2013401. \n                    https:\/\/doi.org\/10.1038\/nature24058","journal-title":"Nature"},{"key":"9793_CR191","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJM199401133300205","volume":"330","author":"GS Tint","year":"1994","unstructured":"Tint GS, Irons M, Elias ER et al (1994) Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 330:107\u2013113. \n                    https:\/\/doi.org\/10.1056\/NEJM199401133300205","journal-title":"N Engl J Med"},{"key":"9793_CR192","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.2012.069872","author":"MA Toward","year":"2013","unstructured":"Toward MA, Abdala AP, Knopp SJ et al (2013) Increasing brain serotonin corrects CO2 chemosensitivity in methyl-CpG-binding protein 2 (Mecp2)-deficient mice. Exp Physiol. \n                    https:\/\/doi.org\/10.1113\/expphysiol.2012.069872","journal-title":"Exp Physiol"},{"key":"9793_CR193","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1073\/pnas.0812394106","volume":"106","author":"D Tropea","year":"2009","unstructured":"Tropea D, Giacometti E, Wilson NR et al (2009) Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci USA 106:2029\u20132034. \n                    https:\/\/doi.org\/10.1073\/pnas.0812394106","journal-title":"Proc Natl Acad Sci USA"},{"key":"9793_CR194","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.semcdb.2016.03.009","volume":"56","author":"M Vacca","year":"2016","unstructured":"Vacca M, Della Ragione F, Scalabr\u00ec F, D\u2019Esposito M (2016) X inactivation and reactivation in X-linked diseases. Semin Cell Dev Biol 56:78\u201387","journal-title":"Semin Cell Dev Biol"},{"key":"9793_CR195","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1086\/444549","volume":"77","author":"H Esch Van","year":"2005","unstructured":"Van Esch H, Bauters M, Ignatius J et al (2005) Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet 77:442\u2013453","journal-title":"Am J Hum Genet"},{"key":"9793_CR196","doi-asserted-by":"publisher","first-page":"11521","DOI":"10.1523\/JNEUROSCI.4373-05.2005","volume":"25","author":"J-C Viemari","year":"2005","unstructured":"Viemari J-C (2005) Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J Neurosci 25:11521\u201311530. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.4373-05.2005","journal-title":"J Neurosci"},{"key":"9793_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.07.029","author":"D Vigli","year":"2018","unstructured":"Vigli D, Cosentino L, Raggi C et al (2018) Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome. Neuropharmacology. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2018.07.029","journal-title":"Neuropharmacology"},{"key":"9793_CR198","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165550","author":"CS Ward","year":"2016","unstructured":"Ward CS, Huang TW, Herrera JA et al (2016) Loss of MeCP2 causes urological dysfunction and contributes to death by kidney failure in mouse models of rett syndrome. PLoS ONE. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0165550","journal-title":"PLoS ONE"},{"key":"9793_CR199","doi-asserted-by":"publisher","first-page":"e115444","DOI":"10.1371\/journal.pone.0115444","volume":"9","author":"E Wegener","year":"2014","unstructured":"Wegener E, Brendel C, Fischer A et al (2014) Characterization of the MeCP2R168X knockin mouse model for Rett syndrome. PLoS ONE 9:e115444. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0115444","journal-title":"PLoS ONE"},{"key":"9793_CR200","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1055\/s-2007-979741","volume":"26","author":"GL Wenk","year":"1995","unstructured":"Wenk GL (1995) Alterations in dopaminergic function in Rett syndrome. Neuropediatrics 26:123\u2013125. \n                    https:\/\/doi.org\/10.1055\/s-2007-979741","journal-title":"Neuropediatrics"},{"key":"9793_CR201","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s11689-016-9156-7","volume":"8","author":"Y Wu","year":"2016","unstructured":"Wu Y, Zhong W, Cui N et al (2016) Characterization of Rett syndrome-like phenotypes in Mecp2-knockout rats. J Neurodev Disord 8:23. \n                    https:\/\/doi.org\/10.1186\/s11689-016-9156-7","journal-title":"J Neurodev Disord"},{"key":"9793_CR202","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1177\/0883073810387138","volume":"26","author":"CY Xi","year":"2011","unstructured":"Xi CY, Lu Y, Tan YH et al (2011) Analysis of MECP2 gene copy number in boys with autism. J Child Neurol 26:570\u2013573. \n                    https:\/\/doi.org\/10.1177\/0883073810387138","journal-title":"J Child Neurol"},{"key":"9793_CR203","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1093\/hmg\/ddt640","volume":"23","author":"DH Yasui","year":"2014","unstructured":"Yasui DH, Gonzales ML, Aflatooni JO et al (2014) Mice with an isoform-ablating Mecp2 exon 1 mutation recapitulate the neurologic deficits of Rett syndrome. Hum Mol Genet 23:2447\u20132458. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddt640","journal-title":"Hum Mol Genet"},{"key":"9793_CR204","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.braindev.2007.04.001","volume":"29","author":"D Young","year":"2007","unstructured":"Young D, Nagarajan L, de Klerk N et al (2007) Sleep problems in Rett syndrome. Brain Dev 29:609\u2013616. \n                    https:\/\/doi.org\/10.1016\/j.braindev.2007.04.001","journal-title":"Brain Dev"},{"key":"9793_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2007.08.009","author":"S Zanella","year":"2008","unstructured":"Zanella S, Mebarek S, Lajard AM et al (2008) Oral treatment with desipramine improves breathing and life span in Rett syndrome mouse model. Respir Physiol Neurobiol. \n                    https:\/\/doi.org\/10.1016\/j.resp.2007.08.009","journal-title":"Respir Physiol Neurobiol"},{"key":"9793_CR206","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.32534","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Zhao Y, Bao X et al (2017) Familial cases and male cases with MECP2 mutations. Am J Med Genet B. \n                    https:\/\/doi.org\/10.1002\/ajmg.b.32534","journal-title":"Am J Med Genet B"},{"key":"9793_CR207","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-016-9169-2","author":"W Zhong","year":"2016","unstructured":"Zhong W, Johnson CM, Wu Y et al (2016) Effects of early-life exposure to THIP on phenotype development in a mouse model of Rett syndrome. J Neurodev Disord. \n                    https:\/\/doi.org\/10.1186\/s11689-016-9169-2","journal-title":"J Neurodev Disord"}],"container-title":["Mammalian Genome"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00335-019-09793-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-019-09793-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-019-09793-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T19:17:21Z","timestamp":1582831041000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00335-019-09793-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":207,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["9793"],"URL":"https:\/\/doi.org\/10.1007\/s00335-019-09793-5","relation":{},"ISSN":["0938-8990","1432-1777"],"issn-type":[{"value":"0938-8990","type":"print"},{"value":"1432-1777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]},"assertion":[{"value":"7 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}